Dolby Laboratories (DLB) FY2014 results: revenue $960 million, up 5.6% on the year
Dolby Laboratories, Inc. (DLB) reported revenue of $960 million for fiscal 2014, the year ended 26 September 2014, up 5.6% on the year before. Net income was $206 million, up 8.9%, and diluted earnings per share $1.99. The figures are the company's own, from the 10-K it filed with the SEC on 18 November 2014.
Revenue
$960 million
+5.6% on the year
FY2008FY2014
Operating margin
28.5%
27.0% a year earlier
FY2008FY2014
Net income
$206 million
+8.9% on the year
FY2008FY2014
Diluted EPS
$1.99
+8.2% on the year
FY2008FY2014
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Revenue
960
910
933
+5.6%
Cost of revenue
70.2
96.7
92.0
-27.4%
Gross profit
890
813
841
+9.5%
Gross margin
92.7%
89.4%
90.1%
Research and development
183
169
140
+8.5%
Operating income
274
245
362
+11.6%
Operating margin
28.5%
27.0%
38.8%
Interest expense
-0.2
0.6
0.2
Pre-tax income
276
251
369
+10.2%
Income tax
67.4
60.3
104
+11.7%
Effective tax rate
24.4%
24.1%
28.1%
Net income
206
189
264
+8.9%
Net margin
21.5%
20.8%
28.3%
Diluted EPS
$1.99
$1.84
$2.46
+8.2%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Operating cash flow
362
277
390
+30.8%
Capital expenditure
75.4
26.7
167
+182.1%
Free cash flow
286
250
222
+14.6%
Free cash flow margin
29.8%
27.5%
23.8%
Cash from investing
-205
175
-195
Cash from financing
-40.6
-488
-254
Depreciation and amortisation
53.3
53.2
43.9
+0.1%
Share-based compensation
65.7
64.3
47.6
+2.1%
Buybacks
56.0
82.2
268
-31.9%
Dividends paid
0.0
408
0.0
Dividend per share
$0.00
$4.00
n/a
Diluted shares, weighted
104m
103m
108m
+0.8%
Balance sheet
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Shareholders' equity
1,710
1,481
1,720
+15.5%
Non-controlling interest
21.6
18.9
23.0
+14.4%
Debt
0.0
0.0
0.0
Other liabilities
252
238
218
+6.1%
Total liabilities and equity
1,984
1,738
1,961
+14.2%
Fixed assets
290
243
255
+19.3%
Goodwill
278
280
281
-0.8%
Intangible assets
63.7
41.3
56.5
+54.2%
Investments
528
447
664
+18.1%
Cash and equivalents
568
454
493
+25.1%
Receivables
86.2
97.5
43.5
-11.6%
Inventory
8.5
10.1
16.7
-15.4%
Other assets
162
165
151
-1.9%
Total assets
1,984
1,738
1,961
+14.2%
10-K for the year ended 26 September 2014, filed 18 November 2014: the filing.